| Literature DB >> 31669643 |
Atena Soleimani1, Farzad Rahmani2, Gordon A Ferns3, Mikhail Ryzhikov4, Amir Avan5, Seyed Mahdi Hassanian6.
Abstract
The NF-κB signaling pathway is a key regulator of CRC cell proliferation, apoptosis, angiogenesis, inflammation, metastasis, and drug resistance. Over-activation of the NF-κB pathway is a feature of colorectal cancer (CRC). While new combinatorial treatments have improved overall patient outcome; quality of life, cost of care, and patient survival rate have seen little improvement. Suppression of the NF-κB signaling pathway using biological or specific pharmacological inhibitors is a potential therapeutic approach in the treatment of colon cancer. This review summarizes the regulatory role of NF-κB signaling pathway in the pathogenesis of CRC for a better understanding and hence a better management of the disease.Entities:
Keywords: Colorectal cancer; NF-κB signaling; Pharmacological inhibitors; Tumorigenesis
Mesh:
Substances:
Year: 2019 PMID: 31669643 DOI: 10.1016/j.gene.2019.144132
Source DB: PubMed Journal: Gene ISSN: 0378-1119 Impact factor: 3.688